2020
DOI: 10.2174/1874467213999200824124532
|View full text |Cite
|
Sign up to set email alerts
|

A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine Drug

Abstract: Background and Objective: Migraine is a neurovascular syndrome associated with unilateral, throbbing headache accompanied with nausea, vomiting and photo/phonophobia. Several proteins are involved in the etiopathogenesis of migraine headache. The aim of the present review is to give an insight into the various target proteins involved in migraine headache pertaining to the development of a potential anti-migraine drug molecule. Proteins/receptors such as serotonin (5-HT), Calcitonin Gene Related Peptide (CGRP)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 189 publications
0
1
0
Order By: Relevance
“…The CGRP is distributed in the peripheral and central nervous system, including the hypothalamus, central gray matter, amygdala, hippocampus, and dentate gyrus (Skofitsch & Jacobowitz, 1985). Because it has been reported that CGRP is released from the trigeminal terminal in an animal model of migraine, accumulating evidence indicates that CGRP is a major contributor to the onset of migraine (Deen et al, 2017;Iyengar et al, 2019;Naduchamy & Parthasarathy, 2020). However, experimental evidence exists that supports the role of CGRP in depressive-like behavior.…”
Section: Introductionmentioning
confidence: 99%
“…The CGRP is distributed in the peripheral and central nervous system, including the hypothalamus, central gray matter, amygdala, hippocampus, and dentate gyrus (Skofitsch & Jacobowitz, 1985). Because it has been reported that CGRP is released from the trigeminal terminal in an animal model of migraine, accumulating evidence indicates that CGRP is a major contributor to the onset of migraine (Deen et al, 2017;Iyengar et al, 2019;Naduchamy & Parthasarathy, 2020). However, experimental evidence exists that supports the role of CGRP in depressive-like behavior.…”
Section: Introductionmentioning
confidence: 99%